[The significance of Th1/Th2 function imbalance in patients with post-infarction cardiac insufficiency]

Xiang Cheng1, Yu-hua Liao, Bin Li

  • 1Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

In patients with post-myocardial infarction (MI) cardiac insufficiency, an imbalance in T helper 1 (Th1)/Th2 cell function, specifically increased Th1 activity, is linked to poorer heart function and may contribute to ventricular remodeling.

Area of Science:

  • Immunology
  • Cardiology
  • Cellular Biology

Context:

  • Post-myocardial infarction (MI) cardiac insufficiency is a significant clinical challenge.
  • The role of T helper (Th) cell subsets, specifically Th1 and Th2, in the pathophysiology of post-MI cardiac dysfunction remains incompletely understood.
  • Understanding immune system modulation in cardiac recovery is crucial for developing novel therapeutic strategies.

Purpose:

  • To investigate the significance of Th1/Th2 function imbalance in patients experiencing cardiac insufficiency after myocardial infarction.
  • To correlate T helper cell cytokine production profiles with the severity of heart function in post-MI patients.

Summary:

  • Forty-three myocardial infarction (MI) patients were classified into two groups based on NYHA heart function classification (MI 1: NYHA I-II, MI 2: NYHA III-IV).
  • Peripheral blood mononuclear cells (PBMCs) were analyzed for cytokine-producing CD4+ T cells (IFN-gamma for Th1, IL-4 for Th2) using flow cytometry and ELISA.
  • Group MI 2 exhibited significantly higher frequencies of IFN-gamma-producing T cells and higher IFN-gamma/IL-4 ratios compared to group MI 1, indicating a shift towards Th1 dominance.

Impact:

  • The findings suggest that Th1/Th2 cell function imbalance, characterized by Th1 cell up-regulation, is associated with impaired heart function in post-MI patients.
  • This imbalance may play a role in the ventricular remodeling process following myocardial infarction.
  • These insights could inform future research into immunomodulatory therapies for post-MI cardiac insufficiency.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...